LANL Cybersecurity Tool, Bioreactor Win Awards

LANL News:
Two technologies developed at Los Alamos National Laboratory were recently recognized at a ceremony by the Federal Laboratory Consortium’s Mid-Continent Region for their contribution to both Los Alamos’ mission and the greater good.
PathScan, a cybersecurity tool that is the result of a partnership between the Laboratory and Ernst & Young, received the Excellence in Technology Transfer Award. In addition, Pulmonary Lung Model (PulMo), abreathing “lung” bioreactor that aims to speed the time-to-market for clinical drugs and allow for more accurate medical testing, received a Notable Technology Development Award.
“It’s always exciting to see technologies developed at Los Alamos recognized for their potential positive impact on everyday lives,” said David Pesiri, head of the Richard P. Feynman Center for Innovation at Los Alamos, which promotes bringing Laboratory-developed technologies to the marketplace. “PathScan has already transitioned to the private sector and is improving cybersecurity, while PulMo has the potential to completely change the way life-saving drugs are tested.”
Stan Brown of Ernst & Young and Steve Stringer, the alliance manager from Feynman Center, accepted the award for PathScan, a network-anomaly detection tool.
PathScan searches for deviations in normal communication patterns that might indicate a cyber intruder. Unlike traditional security tools that look for malware or network signatures, PathScan searches for deviations from normal patterns of communication that are indicative of an intruder’s presence. By creating a deep behavioral model of a network, it can expose intruders and insiders causing local anomalies during their activity.
Los Alamos scientist Pulak Nath and Jennifer Harris received the award for PulMo on behalf of their entire team, a technology that mimics critical functions of the human lung and can be adapted to develop other organs for use as a testing platform to study the effect of a wide range of chemicals on the human body. It could significantly reduce the time and costs associated with bringing a new drug to market and reduce reliance on animals for testing.
The Federal Laboratory Consortium includes all federal agency national laboratories, including Department of Energy facilities like Los Alamos National Laboratory. The Mid-Content Region includes more than 100 national laboratories and facilities from Montana to Texas and Utah to Missouri. The awards ceremony was Sept. 14 in Albuquerque.